News UK's Artios raises $84m to further DDR drug research Management team led development of AZ's PARP drug Lynparza
News NICE okays Pfizer blood cancer drug Besponsa after appeal Life-line drug cancer drug finally available on NHS
News Regeneron forges CAR-T R&D partnership with bluebird bio Deal combines Regeneron's receptor tech with CAR-T biotech's expertise
Market Access FDA grants leukaemia drug ‘breakthrough’ status A leukaemia drug has been granted ‘breakthrough therapy’ status by the US drug regulator.
News NHS saved £324 million by switching to biosimilars and gener... The UK’s national healthcare provider saved £324 million by switching its patients to “better value” biosimilar and generic drugs, which are considered to be “equally effective alternatives
News Parexel buys Vitrana to boost patient safety toolkit Contract research organisation Parexel has bought Vitrana and its AI-powered pharmacovigilance platform for an undisclosed sum.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
